Davion Healthcare Completes $25 Million Acquisition of Medical Technology IP

08:16 AM EDT, 10/26/2026 (MT Newswires) -- Davion Healthcare (DAVI) acquired intellectual property for a smart wound-monitoring dressing and a rapid multi-marker screening platform from Humaskan shareholders in a $25 million deal, the company said Monday. The consideration includes $2.5 million in cash and 1.73 million new ordinary shares valued at a fixed contractual price of $13 each, the company said. WoundSkan uses a smartphone-powered sensor to monitor wound temperature, while Spektra screens for markers linked to certain cancers and other conditions, delivering results in about two minutes. The transaction marks Davion's first acquisition since its Nasdaq direct listing on Oct. 22, the company added. Davion Healthcare shares were down 15% in premarket activity.